2 ASX cannabis shares with big news today

What's going on with these pot stocks today? Let's find out.

| More on:
two men in formal business clothing closely inspect a bud from a cannabis crop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A few years ago the market was abuzz with excitement over ASX cannabis shares or pot stocks.

Since then, the effects have worn off and this side of the market has been getting very little attention.

That was until today when two ASX cannabis shares made big moves in opposite directions. Let's see what is causing the buying and selling.

Cann Group Ltd (ASX: CAN)

The Cann Group share price is up 7% to 4.8 cents on Wednesday after being given a boost from banking giant National Australia Bank Ltd (ASX: NAB).

According to the release, NAB has agreed to defer the quarterly interest payment and facility fee for its construction loan to a future date to be mutually agreed. The interest payment and facility fee total approximately $0.9 million and was due on 22 November.

In addition, the ASX cannabis share revealed that the bank is considering the deferment of the subsequent two quarterly interest and facility fee payments. Furthermore, NAB has confirmed its intention is not to call upon any of the outstanding loan balances during the period through to 29 September 2025.

Management notes that the deferment of up to three quarters of interest payments allows the company to accelerate its trajectory towards critical milestones of positive EBITDA, then positive cash flow.

Cann Group's CEO, Jenni Pilcher, commented:

NAB's ongoing support has been instrumental in positioning Cann for long-term success. This partnership underscores the shared commitment to the company's growth and operational excellence.

Little Green Pharma Ltd (ASX: LGP)

The Little Green Pharma share price is down over 7% to 12.5 cents.

This follows the release of the vertically integrated medicinal cannabis and psychedelics company's half year report.

For the six months, the ASX cannabis share reported a solid 36.8% increase in revenue to $17.5 million. This was driven by sales growth in both domestic and international markets and across most product categories.

However, this top line growth didn't flow through to its bottom line. Instead, its losses widened by 58.7% to approximately $3.5 million.

Though, it is worth noting that its adjusted EBITDA for the half-year was $266,000, which is up from a negative $511,000 in the prior comparative period. This was driven primarily by sales growth and early signs of economies of scale.

Following today's decline, Little Green Pharma's shares are now down over 20% since the start of the year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Cannabis Shares

Man in the green house growing medical cannabis
Cannabis Shares

ASX cannabis stocks eyeing $1 billion domestic market

Legal cannabis use is soaring in Australia.

Read more »

A man in a horse head mask and suit jumps for joy on a beach.
Cannabis Shares

Could ASX cannabis shares be set for a smoking hot rebound?

ASX cannabis stocks could be set for a strong finish to 2024.

Read more »

Man in a cannabis greenhouse looks unhappy and puts his thumb down.
Cannabis Shares

Why are these 2 ASX cannabis stocks sputtering today?

Up 174% in 2023, this ASX cannabis share is giving back some more of its gains today.

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Cannabis Shares

Guess which ASX cannabis share is crashing 36% following an FDA blow

Rookie mistake: This cannabis share just missed out on FDA approval for a simple reason.

Read more »

A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
Cannabis Shares

Could ASX cannabis shares be set for a resurgence?

The world's legal and medical fraternities are taking small steps forward in the medicinal cannabis movement.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Cannabis Shares

This ASX cannabis stock is up 160% since June, and it has an FDA ruling coming up!

Investors are very excited about this cannabis stock.

Read more »

two men in formal business clothing closely inspect a bud from a cannabis crop.
Cannabis Shares

Why ASX cannabis shares just jumped back into the spotlight

ASX cannabis shares operate in a nation where medical marijuana is legal but recreational use remains broadly forbidden.

Read more »

A hip young man with a beard and manbun sits thoughtfully at his laptop computer in a darkened room, staring at the screen with his chin resting on his hand in thought.
Cannabis Shares

Should I buy Incannex shares while they're at multi-year lows, or steer clear?

Is the cannabis-based pharma company a bargain buy right now?

Read more »